معرفی
Erik Aarntzen is a researcher at the University of Groningen, affiliated with the Department of Radiology and Nuclear Medicine at the University Medical Center Groningen. His work focuses on advancing radiomics techniques in PET/CT imaging to improve diagnostic accuracy and personalized treatment strategies in oncology and infectious diseases. He contributes to UN Sustainable Development Goal 3 (Good Health and Well-being) through innovations in medical imaging technologies.
Research interests include:
- PET radiomics analysis for tumor characterization
- Non-invasive diagnostic methods for cancers (e.g., lung cancer)
- Imaging of endothelial activation in conditions like COVID-19
- Genetic clustering of tumors using FDG PET/CT
His recent articles explore topics such as:
- Optimizing radiomic feature sets to reduce redundancy
- Novel imaging techniques for sentinel lymph node identification
- Applications of Gallium-68 and FDG radiotracers in clinical settings
No scientific awards are listed in the provided texts. Collaborations involve multidisciplinary teams across radiology, oncology, and infectious disease research. No student advisees are mentioned. His work often emphasizes methodological improvements in radiomics and translational applications in clinical practice.
